138 related articles for article (PubMed ID: 27206918)
21. Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis.
Thomas TP; Goonewardena SN; Majoros IJ; Kotlyar A; Cao Z; Leroueil PR; Baker JR
Arthritis Rheum; 2011 Sep; 63(9):2671-80. PubMed ID: 21618461
[TBL] [Abstract][Full Text] [Related]
22. The folate receptor β as a macrophage-mediated imaging and therapeutic target in rheumatoid arthritis.
Chandrupatla DMSH; Molthoff CFM; Lammertsma AA; van der Laken CJ; Jansen G
Drug Deliv Transl Res; 2019 Feb; 9(1):366-378. PubMed ID: 30280318
[TBL] [Abstract][Full Text] [Related]
23. Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients.
van der Heijden JW; Oerlemans R; Dijkmans BA; Qi H; van der Laken CJ; Lems WF; Jackman AL; Kraan MC; Tak PP; Ratnam M; Jansen G
Arthritis Rheum; 2009 Jan; 60(1):12-21. PubMed ID: 19116913
[TBL] [Abstract][Full Text] [Related]
24. Antiinflammatory Activity of a Novel Folic Acid Targeted Conjugate of the mTOR Inhibitor Everolimus.
Lu Y; Parker N; Kleindl PJ; Cross VA; Wollak K; Westrick E; Stinnette TW; Gehrke MA; Wang K; Santhapuram HK; You F; Hahn SJ; Vaughn JF; Klein PJ; Vlahov IR; Low PS; Leamon CP
Mol Med; 2015 Jul; 21(1):584-96. PubMed ID: 26181632
[TBL] [Abstract][Full Text] [Related]
25. Prediction of Response to Therapy for Autoimmune/Inflammatory Diseases Using an Activated Macrophage-Targeted Radioimaging Agent.
Kelderhouse LE; Robins MT; Rosenbalm KE; Hoylman EK; Mahalingam S; Low PS
Mol Pharm; 2015 Oct; 12(10):3547-55. PubMed ID: 26333010
[TBL] [Abstract][Full Text] [Related]
26. Folate receptor-β in activated macrophages: ligand binding and receptor recycling kinetics.
Varghese B; Vlashi E; Xia W; Ayala Lopez W; Paulos CM; Reddy J; Xu LC; Low PS
Mol Pharm; 2014 Oct; 11(10):3609-16. PubMed ID: 25166491
[TBL] [Abstract][Full Text] [Related]
27. Folate Receptor Beta for Macrophage Imaging in Rheumatoid Arthritis.
Steinz MM; Ezdoglian A; Khodadust F; Molthoff CFM; Srinivasarao M; Low PS; Zwezerijnen GJC; Yaqub M; Beaino W; Windhorst AD; Tas SW; Jansen G; van der Laken CJ
Front Immunol; 2022; 13():819163. PubMed ID: 35185910
[TBL] [Abstract][Full Text] [Related]
28. Use of folate-conjugated imaging agents to target alternatively activated macrophages in a murine model of asthma.
Shen J; Chelvam V; Cresswell G; Low PS
Mol Pharm; 2013 May; 10(5):1918-27. PubMed ID: 23641923
[TBL] [Abstract][Full Text] [Related]
29. SPECT imaging of joint inflammation with Nanobodies targeting the macrophage mannose receptor in a mouse model for rheumatoid arthritis.
Put S; Schoonooghe S; Devoogdt N; Schurgers E; Avau A; Mitera T; D'Huyvetter M; De Baetselier P; Raes G; Lahoutte T; Matthys P
J Nucl Med; 2013 May; 54(5):807-14. PubMed ID: 23447654
[TBL] [Abstract][Full Text] [Related]
30. Folate-conjugated albumin nanoparticles for rheumatoid arthritis-targeted delivery of etoricoxib.
Bilthariya U; Jain N; Rajoriya V; Jain AK
Drug Dev Ind Pharm; 2015 Jan; 41(1):95-104. PubMed ID: 24164469
[TBL] [Abstract][Full Text] [Related]
31. Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis.
Nakashima-Matsushita N; Homma T; Yu S; Matsuda T; Sunahara N; Nakamura T; Tsukano M; Ratnam M; Matsuyama T
Arthritis Rheum; 1999 Aug; 42(8):1609-16. PubMed ID: 10446858
[TBL] [Abstract][Full Text] [Related]
32. A Phase I/Ib study of folate immune (EC90 vaccine administered with GPI-0100 adjuvant followed by EC17) with interferon-α and interleukin-2 in patients with renal cell carcinoma.
Amato RJ; Shetty A; Lu Y; Ellis PR; Mohlere V; Carnahan N; Low PS
J Immunother; 2014 May; 37(4):237-44. PubMed ID: 24714357
[TBL] [Abstract][Full Text] [Related]
33. Angiopoietin-2 promotes inflammatory activation of human macrophages and is essential for murine experimental arthritis.
Krausz S; Garcia S; Ambarus CA; de Launay D; Foster M; Naiman B; Iverson W; Connor JR; Sleeman MA; Coyle AJ; Hamann J; Baeten D; Tak PP; Reedquist KA
Ann Rheum Dis; 2012 Aug; 71(8):1402-10. PubMed ID: 22730375
[TBL] [Abstract][Full Text] [Related]
34. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
[TBL] [Abstract][Full Text] [Related]
35. Increased uptake of folate conjugates by activated macrophages in experimental hyperlipemia.
Antohe F; Radulescu L; Puchianu E; Kennedy MD; Low PS; Simionescu M
Cell Tissue Res; 2005 May; 320(2):277-85. PubMed ID: 15714274
[TBL] [Abstract][Full Text] [Related]
36. [New immunologic treatment of rheumatoid arthritis].
Sany J
Rev Rhum Ed Fr; 1993 Mar; 60(3):229-39. PubMed ID: 8293009
[TBL] [Abstract][Full Text] [Related]
37. A New Approach for the Treatment of Arthritis in Mice with a Novel Conjugate of an Anti-C5aR1 Antibody and C5 Small Interfering RNA.
Mehta G; Scheinman RI; Holers VM; Banda NK
J Immunol; 2015 Jun; 194(11):5446-54. PubMed ID: 25917104
[TBL] [Abstract][Full Text] [Related]
38. Depletion of synovial macrophages in rheumatoid arthritis by an anti-FcgammaRI-calicheamicin immunoconjugate.
van Roon JA; Bijlsma JW; van de Winkel JG; Lafeber FP
Ann Rheum Dis; 2005 Jun; 64(6):865-70. PubMed ID: 15539412
[TBL] [Abstract][Full Text] [Related]
39. Targeted delivery of catalase and superoxide dismutase to macrophages using folate.
Lee S; Murthy N
Biochem Biophys Res Commun; 2007 Aug; 360(1):275-9. PubMed ID: 17586472
[TBL] [Abstract][Full Text] [Related]
40. Analysing the effect of novel therapies on cytokine expression in experimental arthritis.
Williams RO; Inglis JJ; Simelyte E; Criado G; Sumariwalla PF
Int J Exp Pathol; 2005 Oct; 86(5):267-78. PubMed ID: 16191099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
